News

  1. SMC Pharma Services Enters Autoinjector Development Agreement With A Biopharmaceutical Company For The Bios Platform 10/21/2024

    SMC Pharma Services has partnered with a biopharmaceutical company to develop an autoinjector platform solution for a rare disease clinical trial.

  2. BD And ten23 health® Partner To Advance Efficiency And Quality In Aseptic Manufacturing With RFID-Enabled Prefillable Syringes 10/8/2024

    BD (Becton, Dickinson and Company) and ten23 health announced a collaboration to develop a new way to track refillable syringes using RFID technology.

  3. Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform For Injectable Therapies At CPHI Milan 10/4/2024

    Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology and life sciences industries, announced today the expansion of its Vertiva® platform, which will include a 10mL option to be presented at CPHI Milan in October.

  4. Global CDMO Brings Technological Advancements & Significant Capacity To Ocean County, NJ Location 9/3/2024

    Renaissance Lakewood, LLC (“Renaissance”), a leading pharmaceutical contract development and manufacturing organization (CDMO), today announced the official opening of their new, 67,000 sq ft, expansive warehouse at their recently opened headquarters at 1215 Paco Way in Lakewood, NJ. 

  5. Singota Solutions Announces -40 °C Pallet Storage Offering In EU 8/9/2024

    Singota Solutions, a leading Contract Development and Manufacturing Organization (CDMO), proudly announces the expansion of its service offerings by adding a new -40 °C and -20 °C state-of-the-art pallet storage facility located just outside Milan, Italy.

  6. Shapiro Administration Invests Nearly $3 Million To Bring Adare Pharma Solutions' Headquarters To Pennsylvania, Creating 115 New, Well-Paying Jobs In Philadelphia 8/5/2024

    The life sciences company is investing at least $16.8 million to relocate its headquarters to PA from New Jersey and upgrade its two current Philadelphia facilities, building on Pennsylvania’s reputation as a life sciences leader.

  7. Battelle Prepares To Guide Medical Device Companies Through New Federal, State And International Regulations On "Forever Chemicals" 7/29/2024

    Battelle’s longstanding research, laboratory analysis and consulting expertise in Per- and Polyfluoroalkyl Substances (PFAS) are being applied in a new capacity as the pervasiveness of the chemical class becomes better known and more broadly regulated.

  8. Enable Injections Names New Chief Commercial Officer To Leadership Team 5/30/2024

    As Enable Injections continues to develop and prepare for future commercial success, recent leadership changes and partnership announcements reflect our commitment to commercial growth and supporting our partners with the increasing product demand of enFuse®.

  9. InvestING In Pharmaceutics And Manufacturing Capabilities 4/5/2024
  10. Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession And Board Changes 3/22/2024

    Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that its Board of Directors unanimously approved the conclusion of its review of strategic alternatives that was initiated in March 2023, and, concurrently therewith, announced several strategic updates related to its operations on a stand-alone basis.